首站-论文投稿智能助手
典型文献
Glial cell line?derived neurotrophic factor in brain repair after focal ischemic stroke
文献摘要:
Cerebral focal ischemic stroke (FIS) is a leading brain disorder associated with human debilitation and death. It is induced by the formation of a thrombus in the arteries that supply blood to the central nervous system. FIS patients may suddenly experience paralysis, impairment of speech and loss of vision. Most patients develop permanent disabilities. In the past decades, enormous efforts have been taken to develop FIS treatment strategies, but unfortunately, there is still a lack of effective ones for this disease. Currently, tissue plasminogen activator is the only Food and Drug Administration approved drug for FIS treatment, however, this method has limited application since it is only effective within 3–5 hours after the onset of FIS. Because of this, the recovery from FIS largely depends on self-brain repair and rehabilitation (Campbell et al., 2019).
文献关键词:
作者姓名:
Zhe Zhang;Nannan Zhang;Shinghua Ding
作者机构:
Department of Biomedical,Biological and Chemical Engineering,University of Missouri-Columbia,MO,USA;Dalton Cardiovascular Research Center,University of Missouri-Columbia,MO,USA
引用格式:
[1]Zhe Zhang;Nannan Zhang;Shinghua Ding-.Glial cell line?derived neurotrophic factor in brain repair after focal ischemic stroke)[J].中国神经再生研究(英文版),2022(08):1735-1736
A类:
debilitation
B类:
Glial,cell,line,derived,neurotrophic,brain,repair,after,focal,ischemic,stroke,Cerebral,FIS,leading,disorder,associated,human,death,It,induced,by,formation,thrombus,arteries,that,supply,blood,central,nervous,system,patients,may,suddenly,experience,paralysis,impairment,speech,loss,vision,Most,develop,permanent,disabilities,In,past,decades,enormous,efforts,have,been,taken,treatment,strategies,but,unfortunately,there,still,lack,effective,ones,this,disease,Currently,tissue,plasminogen,activator,only,Food,Drug,Administration,approved,drug,however,method,has,limited,application,since,within,hours,onset,Because,recovery,from,largely,depends,self,rehabilitation,Campbell
AB值:
0.689711
相似文献
Knowledge about,attitude and acceptance towards,and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China:A cross-sectional survey
Jing Hong;Xiao-wan Xu;Jing Yang;Jing Zheng;Shu-mei Dai;Ju Zhou;Qing-mei Zhang;Yi Ruan;Chang-quan Ling-School of Traditional Chinese Medicine,Naval Medical University,Shanghai 200433,China;Department of Integrative Oncology,Changhai Hospital,Naval Medical University,Shanghai 200433,China;Department of Oncology,The First Affiliated Hospital,Bengbu Medical College,Bengbu 233010,Anhui Province,China;Department of Nursing,Fuyang Cancer Hospital,Fuyang 236000,Anhui Province,China;Department of Cardiac Rehabilitation,Shanghai First Rehabilitation Hospital,Shanghai 200090,China;Department of Radiation Oncology,Anhui Chest Hospital,Hefei 230022,Anhui Province,China;Department of Anesthesiology,Chaohu Hospital,Anhui Medical University,Hefei 238000,Anhui Province,China
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD:A promising drug Potentilla discolor Bunge
Longshan Ji;Qian Li;Yong He;Xin Zhang;Zhenhua Zhou;Yating Gao;Miao Fang;Zhuo Yu;Robim M.Rodrigues;Yueqiu Gao;Man Li-Laboratory of Cellular Immunity,Institute of Clinical Immunology,Shanghai Key Laboratory of Traditional Chinese Medicine,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Key Laboratory of Liver and Kidney Diseases(Shanghai University of Traditional Chinese Medicine),Ministry of Education,Shanghai 201203,China;Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Department of Hepatopathy,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of in Vitro Toxicology and Dermato-Cosmetology,Faculty of Medicine and Pharmacy,Vrije Universiteit Brussel,Brussels 1000,Belgium
Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosis
Fang Wang;Jia-nan Wang;Xiao-yan He;Xiao-guo Suo;Chao Li;Wei-jian Ni;Yu-ting Cai;Yuan He;Xin-yun Fang;Yu-hang Dong;Tian Xing;Ya-ru Yang;Feng Zhang;Xiang Zhong;Hong-mei Zang;Ming-ming Liu;Jun Li;Xiao-ming Meng;Juan Jin-Inflammation and Immune Mediated Diseases Laboratory of Anhui Province,Anhui Institute of Innovative Drugs,School of Pharmacy,Anhui Medical University,The Key Laboratory of Anti-inflammatory of Immune Medicines,Ministry of Education,Hefei 230032,China;Department of Pharmacy,Anhui Provincial Hospital,The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei 230001,China;Hospital of Stomatology,Anhui Medical University,Key Laboratory of Oral Diseases Research of Anhui Province,Hefei 230032,China;Department of Pharmacy,Changzheng Hospital,Naval Medical University,Shanghai 200003,China;Department of Nephrology,Sichuan Academy of Medical Sciences&Sichuan Provincial People's Hospital,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610072,China;School of Basic Medical Sciences,Anhui Medical University,Hefei 230032,China
Novel Caspase-1 inhibitor CZL80 improves neurological function in mice after progressive ischemic stroke within a long therapeutic time-window
Ling Pan;Wei-dong Tang;Ke Wang;Qi-feng Fang;Meng-ru Liu;Zhan-xun Wu;Yi Wang;Sun-liang Cui;Gang Hu;Ting-jun Hou;Wei-wei Hu;Zhong Chen;Xiang-nan Zhang-Institute of Pharmacology and Toxicology,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou 310058,China;Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province,School of Pharmaceutical Sciences,Zhejiang Chinese Medical University,Hangzhou 310053,China;Department of Pharmachemistry,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou 310058,China;Department of Pharmacology,School of Medicine and Life Sciences,Nanjing University of Chinese Medicine,Nanjing 210029,China
Celastrol suppresses the growth of vestibular schwannoma in mice by promoting the degradation of β-catenin
Na Hui Kim;Minji Kwon;Jiwoo Jung;Hyo Byeong Chae;Jiwoo Lee;Yeo-Jun Yoon;In Seok Moon;Ho K.Lee;Wan Namkung;Konstantina M.Stankovic;Se A.Lee;Jong Dae Lee;Sin-Aye Park-Department of ICT Environmental Health System,Graduate School,Soonchunhyang University,Asan-si 31538,Republic of Korea;Department of Biomedical Laboratory Science,College of Medical Sciences,Soonchunhyang University,Asan-si 31538,Republic of Korea;Department of Otorhinolaryngology,Yonsei University,College of Medicine,Seoul 03722,Republic of Korea;Colllege of Pharmacy and Yonsei Institute of Pharmaceutical Sciences,Yonsei University,Yeonsu-gu,Incheon 21983,Republic of Korea;Department of Otolaryngology-Head and Neck Surgery,Stanford University School of Medicine,Stanford,CA 94305,USA;Department of Otorhinolaryngology-Head and Neck Surgery,Soonchunhyang University Bucheon Hospital,Bucheon 14584,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。